# FDA Inspection 1164256 - Octapharma Plasma, Inc. - February 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6b0516eb-3139-4f07-a470-4b88fde33362
Source feed: FDA_Inspections

> FDA Inspection 1164256 for Octapharma Plasma, Inc. on February 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164256
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2022-02-16
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1164256 - 2022-02-16](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/7bae96f2-14aa-49d6-bd33-34e46364b5dc)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/be920309-6cbf-43b6-a543-374bbbd38dbd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d